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Mature  human  myeloid  cells  (granulocytes)  maintain  a  number  of important 
functional characteristics including those providing a defense against invading micro- 
organisms.  Circulating granulocytes accumulate  at  sites  of microbial  invasion  by 
chemotaxis, a  process  directing migration along a  chemical gradient  provided  by 
microbial  products  (1).  The  presence  of complement  receptors  on  membranes  of 
certain granulocytes (2, 3) may facilitate recognition and subsequent phagocytosis of 
opsonized micro-organisms (4). Once phagocytosis has occurred, a complex oxidative 
metabolic process involving the rapid generation of superoxide anion (02-)  and its 
interaction with certain granulocytic enzymes results in killing of the ingested micro- 
organisms (5, 6, 7). 
We have recently developed a unique human cell line (designated HL-60) from the 
peripheral blood leukocytes of a  patient with acute promyelocytic leukemia. These 
cultured cells are predominantly promyelocytes and display distinct morphological 
and  histochemical  myeloid  characteristics  (8).  When  incubated  for  5-7  d  with 
appropriate concentrations of dimethylsulfoxide (Me2SO), the majority of  the cultured 
cells  differentiate  into  morphologically  mature  myelocytes, metamyelocytes, and 
banded and segmented neutrophils (9). Our initial studies demonstrated that these 
induced cells were capable of phagocytizing certain micro-organisms (9). We report 
here  that  the  cultured  HL-60  cells  despite  their  leukemic  origin  and  karyotypic 
abnormalities (8)  are induced by Me2SO to display functional characteristics com- 
monly associated with normal peripheral  blood granulocytes including response to 
chemoattractants  and  development  of complement  receptors.  Moreover,  phorbol 
myristate acetate (PMA) which induces phagocytosis-associated oxidative metabolism 
in normal granulocytes (10,  11)  similarly induces the Me2SO-treated HL-60 cells to 
generate superoxide anion and reduce nitroblue tetrazolium (NBT) dye. 
Materials and Methods 
Cells.  The HL-60 cell line has been maintained in continuous suspension culture for over 
2  yr and  100  passages as  previously  described  (8). The  experiments  reported  here  were 
performed on cells between passage 10 and 40. Me2SO-induced cells were obtained by seeding 
HL-60 cells at 2.5  ×  105/ml in growth media and culturing for 6 d in the presence of 1.12% 
Me2SO (9). Control cells included K-562, an undifferentiated cell line derived from a patient 
with chronic  myeloid leukemia  in blast  crisis (12). These  cells were grown under standard 
conditions  in RPMI-1640  media (Grand  Island Biological Co., Grand Island, N. Y.) supple- 
mented with 20% heat inactivated fetal calf serum (Flow Laboratories, Inc., Rockville, Md.). 
Peripheral blood granulocytes from normal donors were obtained by the Ficoll-dextran method 
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(13) and consisted of >95% fully mature segmented polys. All cells were washed twice in plain 
RPMI before functional assays were performed.  Differential counts of cell  suspensions were 
performed on cytospin slide preparations stained with Wright-Giemsa as previously described 
(9), 
Chemotaxis.  The assay was based on the modified Boyden chamber procedure  (14). Cells 
were added to the upper well of a blind well chamber (model F013WLB00101, Neuro Probe, 
Inc., Bethesda, Md.)  at a concentration of 2.5  X  10  s cells/ml of Gey's balanced salt solution 
containing 2% bovine serum albumin. The potent chemoattractant f-met-leu-phe (15) (Andrulis 
Research Corp., Bethesda,  Md.)  was added to the lower well at  a  concentration of 10  -9 M 
diluted in phosphate-buffered saline.  (A)  13-mm chemotactic membrane (Nucleopore Corp., 
Pleasanton, Calif.) containing an average pore diameter of 5.0 #m separated the two compart- 
ments.  The  membranes  were  then  removed,  stained  with  Wright-Giemsa  and  examined 
microscopically for cells that had migrated through the pores to the underside. The number of 
cells in four successive  low power fields  (X  160) were then counted and averaged in triplicate 
experiments. 
Complement Receptors.  Complement receptors were determined by the erythrocyte antibody 
complement-(EAC)  rosetting technique  (16) with  sheep erythrocytes (RBC)  sensitized  with 
rabbit anti-sheep RBC IgG (Grand Island Biological Co.) with DBA2 mouse serum (Associated 
Biomedic Systems, Buffalo, N. Y.) as the source of complement. 
Superoxide Production and NBT Reduction.  Generation  of superoxide  was  measured  by the 
ability of this anion to reduce ferricytochrome c, the reduced ferrocytochrome molecule having 
a  higher absorhance at  550  nm  (6,  7).  The stimulus  for generation was provided by PMA 
obtained from the National Institutes of Health carcinogen repository and stored at  -20 in 
100% acetone at  a  concentration of 500 lag/ml.  1 ml of phosphate-buffered saline  (pH  7.4) 
containing 5  X  106 cells, 0.12  mM ferricytochrome c  (Sigma Chemical Co., St.  Louis, Mo.) 
and,  where  appropriate,  100  ng  freshly  diluted  PMA  with  or  without  60  lag  superoxide 
dismutase (SOD) (Sigma Chemical Co.) was incubated for 20 rain at 37°C. The reaction was 
then stopped by submerging the tubes in an ice bath, the cells were pelleted by centrifugation 
at 4°C at 200 g for 5 min, and the absorbance of the supernate at 550 nm was then determined 
in a Gilford 240 spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio). The 
quantity  of superoxide  generated  was expressed  as  the  AA/20 min/5  ×  106 cells  which  is 
inhibited by 60 lag SOD. 
For NBT reduction studies  1 ml of cells  suspended at  2  ×  l0  B cells/ml of RPMI media 
supplemented with 20% fetal calf serum was incubated for 20 rain with an equal voi of 0.2% 
NBT (Aldrich Chemical Co., Milwaukee, Wis.)  dissolved in phosphate-buffered saline in the 
presence and absence of 200 ng freshly diluted PMA. The percent of cells containing intracel- 
lular reduced blue-black formazan deposits was then determined on Wright-Giemsa stains of 
eytospin preparations of the incubated cells. 
Results  and  Discussion 
Chemotaxis.  Me2SO-induced  HL-60  cells,  which  consist  predominantly  of meta- 
myeloeytes and bands rather than segmented neutrophils, the final cells in the myeloid 
series (9), consistently showed a greater response to the chemoattractant f-met-leu-phe 
than  either  uninduced  HL-60  or  K-562  cells  (Table  I).  Moreover,  these  relatively 
immature Me2SO-treated cells often responded better than more fully mature periph- 
eral  blood  neutrophils  (Table  I).  This  may  reflect  a  greater  adaptability  of the 
cultured,  induced HL-60 cells to the artificial  in vitro chemotactic assay conditions. 
The  migrating  cells  in  the  unindueed  promyelocytic culture  (Table  I)  upon  close 
microscopic  examination  appear  to  be  more  mature  myeloid  cells  and  probably 
represent  the small percentage of myeloid cells spontaneously differentiating beyond 
the promyelocytic stage that are found in the uninduced HL-60 culture  (8).  Similar 
results have been obtained by using f-met-leu (10  -7 M)  (Sigma Chemical Co.) as the 
ehemoattraetant.  (17). 
Complement Receptors.  HL-60  cells  induced  with  Me2SO  consistently  showed  an COLLINS ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE I 
Chemotaxis Assay of Cultured Human Leukocytes 
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Mature myeloid  Cells  cells* 
Migrating celIs/4LPF (×  160) 
-Chemoattrac-  + Chemoattrac- 
tant  tant$ 
% 
HL-60-uninduced  8-12  8 ±  3  38 ±  8 
HL-60-induced§  75-85  25 ±  10  346 ±  150 
Peripheral blood granuloeytes  >95  17 ±  8  220 4-  86 
K-562  0  6 ±  4  7 ±  3 
* Myelocytes, metamyelocytes, banded and segmented neutrophils on Wright-Giemsa stained preparations 
of cell suspensions. 
$10  -9 M f-met-leu-phe. 
§ Induced with 1.12% Me2SO as described in Materials and Methods. 
II Numbers equal the average number of migrating cells ±  the observed range in triplicate experiments. 
TABLE II 
Complement Receptors on Human Leukocytes 
Cells  Mature myeloid cells*  EAC rosettes 
%  % 
HL-60-uninduced  8-12  7 ±  2§ 
HL-60-induced$  75-85  24 ±  9 
Peripheral blood granulocytes  >95  <3 
K-562  0  <3 
* Myelocytes, metamyelocytes, banded and segmented neutrophils. 
$ Induced with 1.12% Me2SO as described in Materials and Methods. 
§ Numbers  represent average percent  of rosetting cells  ±  the  observed range  in 
triplicate experiments. 
increased percentage of EAC rosetting when compared with uninduced cells and with 
normal  peripheral  blood  granulocytes  (Table  II).  Because  the  HL-60 induced  cells 
consist  predominantly  of relatively  immature  granulocytes  (9)  although  the  Ficoll- 
dextran  isolated  peripheral  blood  granulocytes  are  almost  exclusively  fully mature 
segmented polys, these results are consistent with previous findings that receptors for 
certain  complement  components  present  on  immature  granulocytes  are  lost  as  the 
granulocytes  become  fully  mature  (2,  3).  Further  studies  with  EAC  complexes 
prepared  from purified  components  of human  complement  are  necessary  to verify 
these results  (18). 
Superoxide Generation and NBT Dye Reduction.  Both uninduced and Me2SO-induced 
HL-60 cells  were consistently  stimulated  by PMA  to  generate  superoxide  with  the 
level generated by induced cells comparable to that generated by normal peripheral 
blood granulocytes (Table III). These results are further substantiated by studies with 
NBT dye reduction.  NBT, a water soluble dye, is converted to insoluble intracellular 
blue formazan by phagocytizing neutrophils  (19), a  reaction mediated by superoxide 
(20). Both normal granulocytes and Me2SO-induced HL-60 cells stimulated by PMA 
show a  higher percentage of cells reducing the dye than the uninduced HL-60 as well 
as  control  K-562  cells  (Table  IV).  The  intracellular  precipitation  of the  reduced 
formazan crystals precludes adequate morphological assessment of the particular cells 
reducing the dye, but  the close correlation  between  the percent  of mature cells in a 972  COLLINS ET AL.  BRIEF DEFINITIVE REPORT 
TABLE III 
Superoxide Generation by Human Leukocytes 
Cells  Mature myeloid cells* 
O2- generated (Asso $/5  ×  106 cells/20 min) 
-PMA  + PMA, 100 ng/ml 
% 
HL-60-uninduced  8-12  0.089 ±  0.3511  0.228 ±  0.038 
HL-60-induced§  75-85  0.062 ±  0.022  1.111 ±  0.086 
Peripheral  blood  >95  0.020 ±  0.008  1.045 +  0.075 
granulocytes 
K-562  0  0.028 ±  0.003  0.052 ±  0.018 
* Myelocytes, metamyelocytes, banded and segmented neutrophils. 
$ Numbers represent  the changes in absorbance at 550 nm of incubated reaction mixtures (see Materials 
and Methods)  which are inhibited by 60 #g of superoxide dismutase. 
§ Induced with 1.12% Me2SO as described in Materials and Methods. 
II Numbers represent the mean with :t: the range in triplicate experiments. 
TABLE IV 
NBT Reduction by Human Leukocytes 
Cells  Mature myeloid cells* 
Cells reducing NBT$ 
--  PMA  + PMA, 
100 ng/ml 
%  % 
HL-60-uninduced  8-12  < 1  8 
HL-60-indueed§  75-85  <1  72 
Peripheral  blood  >95  < 1  >90 
granulocytes 
K-562  0  < 1  < 1 
* Myeloeytes, metamyelocytes, banded and segmented neutrophils. 
$ Percent of cells containing blue-black formazan deposits as determined on Wright-Giemsa 
stains ofcytospin preparations of cell suspensions incubated with NBT solution as described 
in Materials and Methods. 
§ Induced with 1.12% Me2SO as described in Materials and Methods. 
culture  and  the  percent  of cells  reducing  NBT  (Table  IV)  suggests  that  it  is  the 
mature  myeloid  cells  rather  than  the  immature  promyelocytes  that  are  generating 
superoxide in both uninduced and Me2SO-induced PMA  stimulated HL-60 cultures. 
Thus, the HL-60 leukemia cells, which were derived from a  patient who ultimately 
died  from  promyelocytic leukemia  1 and  which  maintain  distinct karyotypic  abnor- 
malities (8) 1  , can be induced under appropriate stimuli to differentiate to morpholog- 
ically mature  granulocytes performing many  of the  functions commonly  associated 
with  normal peripheral  blood granulocytes including response to chemoattractants, 
development of complement receptors,  phagocytosis  (9), superoxide production, and 
NBT  dye  reduction.  In related  studies,  murine myeloid  leukemic cells displaying a 
similar in vivo block in differentiation can be induced in vitro to mature functioning 
granulocytes  (21).  These  experiments  indicate  that  certain  myeloid  leukemic  cells 
maintain the genetic capability to function as normal granulocytes but the expression 
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of these genes in vivo is blocked by some unknown  mechanism. The etiology of this 
in  vivo  block  in  differentiation  found  in  HL-60  as  well  as  other  human  myeloid 
leukemia cells is currently being investigated in our laboratory. Moreover, the HL-60 
cell  line,  which  is  capable  of switching  on  such  distinct  differentiation  markers, 
provides a model system for studying nuclear and cytoplasmic protein changes as well 
as variations in messenger RNA expression in differentiating myeloid cells. 
Summary 
The HL-60 human promyelocytic leukemia cell line can be induced to terminally 
differentiate to mature myeloid cells sharing a  number of functional  characteristics 
with  normal  granulocytes  including  response to  chemoattractants,  development  of 
complement receptors, phagocytosis, superoxide production,  and  nitroblue  tetrazo- 
lium dye reduction. Hence the Me2SO-induced HL-60 cells provide a unique in vitro 
model for studying various important aspects of human myeloid cell differentiation. 
Received for publication  4 January  1979. 
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